Jan Voss
Lead Pharmacologist Skape Bio
Jan Hendrik Voss, PhD, is Lead Pharmacologist at Skape Bio, where he leads the pharmacological characterization of de novo designed miniproteins targeting G protein-coupled receptors. With a background in molecular pharmacology and GPCR signaling, he develops functional assays, guides miniproteins from screening through mechanistic and translational studies, and contributes to the selection of drug targets.
Seminars
Tuesday 2nd March 2027
Engineering De Novo Miniprotein GPCR Modulators to Unlock Novel Therapeutic Opportunities
12:00 pm
- 12:29 pm
- Combining protein design with genetically encoded high-throughput screening to accelerate the discovery of functional GPCR agonists and antagonists
- Expanding the druggable GPCR landscape by engineering miniproteins against previously challenging and underexplored receptors
- Advancing miniproteins as a therapeutic modality to deliver differentiated selectivity, functionality and drug-like properties
